Axsome Therapeutics Inc (NASDAQ:AXSM)
| 44.73 BATS BZX Real-Time Price As of 9:38am ET |  +0.54 / +1.22%Today’s Change | 20.63 Today|||52-Week Range 71.98 | +18.40% Year-to-Date |
Latest AXSM News | Press Releases
| 2 No-Brainer Biotech Stocks to Buy Right Now Sep 26 / MotleyFool.com - Paid Partner Content | 2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell Sep 22 / MotleyFool.com - Paid Partner Content |
| 3 Monster Stocks in the Making Sep 24 / MotleyFool.com - Paid Partner Content | 2 Biotech Stocks That Could Make You Richer Sep 17 / MotleyFool.com - Paid Partner Content |
| If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today Sep 23 / MotleyFool.com - Paid Partner Content | Is It Too Late to Buy Axsome Therapeutics Stock? Sep 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 44.19 |
| Today’s open | 46.56 |
| Day’s range | 43.95 - 44.73 |
| Volume | 1,409 |
| Average volume (3 months) | 1,651,840 |
| Market cap | $2.0B |
Data as of 9:38am ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -25.34% |
| Earnings growth (this year) | -24.53% |
| Earnings growth (next 5 years) | +1.40% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 121.60 |
Competitors
Data as of 9:38am ET, 09/30/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | -$1.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$130.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
